LAISING YEN to CRISPR-Cas Systems
This is a "connection" page, showing publications LAISING YEN has written about CRISPR-Cas Systems.
Connection Strength
0.088
-
Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma. Proc Natl Acad Sci U S A. 2015 Mar 17; 112(11):E1272-7.
Score: 0.088